JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Frankle, W. G.
Right arrow Articles by Laruelle, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Frankle, W. G.
Right arrow Articles by Laruelle, M.
Journal of Nuclear Medicine Vol. 47 No. 5 815-826
© 2006 by Society of Nuclear Medicine


Basic Science Investigation

Estimation of Serotonin Transporter Parameters with 11C-DASB in Healthy Humans: Reproducibility and Comparison of Methods

W. Gordon Frankle1, Mark Slifstein1, Roger N. Gunn2, Yiyun Huang1,3, Dah-Ren Hwang1,3, E. Ashlie Darr1, Rajesh Narendran1, Anissa Abi-Dargham1,3 and Marc Laruelle1,3

1 Department of Psychiatry, Columbia University College of Physicians and Surgeons and the New York State Psychiatric Institute, New York, New York; 2 Translational Medicine and Genetics, GlaxoSmithKline, Greenford, United Kingdom; and 3 Department of Radiology, Columbia University College of Physicians and Surgeons and the New York State Psychiatric Institute, New York, New York

Correspondence: For correspondence or reprints contact: W. Gordon Frankle, MD, New York State Psychiatric Institute, 1051 Riverside Drive, Box 31, New York, NY 10032. E-mail: wf2004{at}columbia.edu

The aim of the present study was to define the optimal analytic method to derive accurate and reliable serotonin transporter (SERT) receptor parameters with 11C-3-amino-4-(2-[(dimethylamino)methyl]phenylthio)benzonitrile (11C-DASB). Methods: Nine healthy subjects (5 females, 4 males) underwent two 11C-DASB PET scans on the same day. Five analytic methods were used to estimate binding parameters in 10 brain regions: compartmental modeling with 1- and 2-tissue compartment models (1TC and 2TC), data-driven estimation of parametric images based on compartmental theory (DEPICT) analysis, graphical analysis, and the simplified reference tissue model (SRTM). Two variations in the fitting procedure of the SRTM method were evaluated: nonlinear optimization and basis function approach. The test/retest variability (VAR) and intraclass correlation coefficient (ICC or reliability) were assessed for 3 outcome measures: distribution volume (VT), binding potential (BP), and specific to nonspecific equilibrium partition coefficient (V3''). Results: All methods gave similar values across all regions. The variability of VT was excellent (≤10%) in all regions, for the 1TC, 2TC, DEPICT, and graphical approaches. The variability of BP and V3'' was good in regions of high SERT density and poorer in regions of moderate and lower densities. The ICC of all 3 outcome measures was excellent in all regions. The basis function implementation of SRTM demonstrated improved reliability compared with nonlinear optimization, particularly in moderate and low-binding regions. Conclusion: The results of this study indicate that 11C-DASB can be used to measure SERT parameters with high reliability and low variability in receptor-rich regions of the brain, with somewhat less reliability and increased variability in regions of moderate SERT density and poor reproducibility in low-density regions.

Key Words: serotonin transporter • 11C-DASB • PET • kinetic modeling • reproducibility




This article has been cited by other articles:


Home page
J. Neurosci.Home page
R. A. Rhodes, N. V. Murthy, M. A. Dresner, S. Selvaraj, N. Stavrakakis, S. Babar, P. J. Cowen, and P. M. Grasby
Human 5-HT Transporter Availability Predicts Amygdala Reactivity In Vivo
J. Neurosci., August 22, 2007; 27(34): 9233 - 9237.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
N. Costes, L. Zimmer, A. Reilhac, F. Lavenne, P. Ryvlin, and D. Le Bars
Test Retest Reproducibility of 18F-MPPF PET in Healthy Humans: A Reliability Study
J. Nucl. Med., August 1, 2007; 48(8): 1279 - 1288.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2006 by the Society of Nuclear Medicine.